Assesment of Multiomics Profiles in Health and Disease. (ENIGMA)
Assesment of Multiomics Profiles in Health and Disease - Corelation With the Disease Phenotype.
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic
This observational or N/A phase trial investigates Genetic Predisposition to Disease and is currently actively recruiting participants. The Institute of Molecular and Translational Medicine, Czech Republic leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Oct 2024 — Feb 2026 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Sep 2022 — Sep 2023 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Institute of Molecular and Translational Medicine, Czech Republic
For direct contact, visit the study record on ClinicalTrials.gov .